Letter to Editor

Ventilator-Associated Pneumonia Prevention Strategies in Patients with Brain Damage

[1] Mirtalaei N, Farazi A, Monfared ME, Jokar A. Efficacy of Antibiotic Prophylaxis against ventilator-associated pneumonia. J Hosp Infect. 2019; 101(3); 272-275.
[2] Dahyot-Fizelier C, Lasocki S, Kerforne T, Perrigault PF, Geeraerts T, Asehnoune K, et al. Ceftriaxone to prevent early ventilator-associated pneumonia in patients with acute brain injury: a multicentre, randomised, double-blind, placebo-controlled, assessor-masked superiority trial. Lancet Respir Med. 2024; 12(5):375-85.
[3] Cotoia A, Spadaro S, Gambetti G, Koulenti D, Cinnella G. Pathogenesis-targeted preventive strategies for multidrug resistant ventilator-associated pneumonia: a narrative review. Microorganisms. 2020; 8(6):821.
[4] Zha S, Niu J, He Z, Fu W, Huang Q, Guan L, et al. Prophylactic antibiotics for preventing ventilator-associated pneumonia: a pairwise and Bayesian network meta-analysis. Eur J Med Res. 2023; 28(1):348.
[5] Su M, Jia Y, Li Y, Zhou D, Jia J. Probiotics for the prevention of ventilator-associated pneumonia: a meta-analysis of randomized controlled trials. Respir Care. 2020; 65(5):673-85.
Files
IssueArticle in Press QRcode
SectionLetter to Editor
Keywords
Ventilator-associated pneumonia prevention antibiotic prophylactic probiotic

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Jabbari A, Tabasi S, Mirzaei H. Ventilator-Associated Pneumonia Prevention Strategies in Patients with Brain Damage. Arch Anesth & Crit Care. 2024;.